FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to method of obtaining fluorescent derivatives of dextrans intended for studying transport of biologically active substances through cell membranes and studying mechanisms of medication action at cell and subcell levels. Method of obtaining includes carrying out reaction of fluorescent dye with activated oxidised dextran with further purification of final product from admixtures by ultra filtration. As fluorescent dye used is fluorescein, as activating agent -1,1'-carbonyldiimidasol, activation of oxidised dextran being carried out by addition of 1,1'-carbonyldiimidasol in reaction mixture of oxidised dextran with fluorescein.
EFFECT: increase of method efficiency.
5 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING BIOTINYLATED DERIVATIVE OF OXIDISED DEXTRAN | 2013 |
|
RU2537246C1 |
METHOD OF PRODUCING OXIDISED DEXTRAN, SUITABLE FOR ITS VISUALIZATION IN BLOOD SERUM | 2019 |
|
RU2690380C1 |
METHOD FOR PRODUCING FLUORESCENT DERIVATIVES OF ARABINOGALACTAN | 2021 |
|
RU2768707C1 |
METHOD FOR INCREASING NATURAL RESISTANCE OF YOUNG CATTLE | 2022 |
|
RU2794852C1 |
METHOD FOR OXIDIZED DEXTRAN OBTAINING | 2016 |
|
RU2618341C1 |
MEDICATION FOR PREVENTION OF BIRD FLU IN MAMMALS | 2010 |
|
RU2437664C1 |
DRUG STIMULATING PRODUCTION OF GRANULOCYTE-MACROPHAGE COLONY-FORMING FACTOR IN CELLS OF MONONUCLEAR PHAGOCYTE SYSTEM | 2010 |
|
RU2438676C1 |
METHOD FOR PREVENTION OF EIMERIOSIS IN CHICKENS | 2020 |
|
RU2750707C1 |
METHOD FOR THE PREVENTION OF MASTITIS IN CATTLE | 2022 |
|
RU2794621C1 |
METHOD FOR CELLULAR LABORATORY IMMUNITY OF LABORATORY ANIMALS | 2018 |
|
RU2709809C1 |
Authors
Dates
2011-08-20—Published
2010-04-26—Filed